Nrx pharmaceuticals to participate in lifesci corporate access event

Radnor, pa. , dec. 11, 2023 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, today announced the company will be participating in-person at the lifesci partners corporate access event for three days from january 8 th through the 10th in san francisco.

NRXP Ratings Summary

NRXP Quant Ranking